Biointron is excited to announce our participation in World ADC Asia 2025, set to take place in Incheon, South Korea, from June 10-12, 2025. This premier event is dedicated to accelerating the development of antibody-drug conjugates (ADCs), uniting experts from across the biopharmaceutical industry to share insights, showcase innovations, and drive forward the future of targeted therapeutics.

Biointron is excited to announce our participation in BioPlus-Interphex Korea 2025, taking place October 15-17, 2025, in Seoul, South Korea. This premier event brings together leaders in biotechnology, pharmaceuticals, and healthcare to showcase innovations, discuss industry trends, and foster collaboration across the life sciences sector.

Biointron is thrilled to announce our participation in BIO KOREA 2025, scheduled for May 7-9, 2025, in Seoul, South Korea. Biointron is proud to join this dynamic forum and contribute to the advancement of biopharmaceutical science and innovation.

Biointron is thrilled to announce our participation in CPHI Japan 2025, one of Asia’s most influential pharmaceutical events, set to take place from April 9-11, 2025, in Tokyo, Japan.